Jazz Pharmaceuticals EPS - Earnings per Share 2010-2024 | JAZZ

Jazz Pharmaceuticals earnings per share (EPS) for the twelve months ending December 31, 2024 was $8.65, a 41.8% increase year-over-year.

  • Jazz Pharmaceuticals EPS for the quarter ending December 31, 2024 was $2.97, a 112.14% increase year-over-year.
  • Jazz Pharmaceuticals 2024 annual EPS was $8.65, a 41.8% increase from 2023.
  • Jazz Pharmaceuticals 2023 annual EPS was $6.1, a 270.39% decline from 2022.
  • Jazz Pharmaceuticals 2022 annual EPS was $-3.58, a 35.14% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Jazz Pharmaceuticals EPS - Earnings per Share 2010-2024 | JAZZ

  • Jazz Pharmaceuticals EPS for the quarter ending December 31, 2024 was $2.97, a 112.14% increase year-over-year.
  • Jazz Pharmaceuticals 2024 annual EPS was $8.65, a 41.8% increase from 2023.
  • Jazz Pharmaceuticals 2023 annual EPS was $6.1, a 270.39% decline from 2022.
  • Jazz Pharmaceuticals 2022 annual EPS was $-3.58, a 35.14% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.